Skip to main content
Coloplast logo

Coloplast — Investor Relations & Filings

Ticker · COLO ISIN · DK0060448595 LEI · 529900NN7SOJ5QG82X67 CO Manufacturing
Open in API
Filings indexed 2,462 across all filing types
Latest filing 2025-09-02 Regulatory Filings
Country DK Denmark
Listing CO COLO

About Coloplast

https://www.coloplast.com

Coloplast is a company that develops, manufactures, and markets medical devices and services for people with intimate healthcare needs. Its principal business areas include Ostomy Care, Continence Care, Interventional Urology, and Wound & Skin Care. By collaborating closely with users, the company creates solutions designed to make life easier for individuals with personal and private medical conditions. Coloplast also provides comprehensive support programs and educational resources for both patients and healthcare professionals.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2025
Regulatory Filings Classification · 1% confidence The document is an announcement regarding Coloplast's new 5-year strategy ('Impact4') and its associated long-term financial ambitions (CAGR, EBIT, ROIC targets). It serves as a preview and invitation to a Capital Markets Day event. It does not contain the full presentation slides or the full financial report, but rather summarizes the strategic outlook and provides a link to the upcoming event materials. Therefore, it is classified as a Regulatory Filing (RNS) as it is a corporate announcement of strategic guidance.
2025-09-02 English
Management Reports 2025
Management Reports Classification · 1% confidence The document is an announcement from Coloplast A/S regarding new financial expectations and the launch of a 5-year strategy ('Impact4'). It provides key financial targets and mentions an upcoming Capital Markets Day. Crucially, the document concludes with a 'Vedhæftet fil' (Attached file) section, which provides a link to the actual presentation/report. Following the 'Menu vs Meal' rule, since this is a short announcement (under 5,000 characters of core content excluding boilerplate) that explicitly points to an attached file for the full details, it is classified as a Report Publication Announcement (RPA).
2025-09-02 Danish
Earnings Release 2030
Earnings Release Classification · 1% confidence The document is a corporate announcement regarding Coloplast's new 5-year strategy ('Impact4') and updated long-term financial expectations presented at their Capital Markets Day. While it contains financial projections, it is an announcement of a strategy update and an invitation to a Capital Markets Day event, rather than a full financial report or a transcript. It fits best under 'Investor Presentation' (IP) as it outlines the strategic and financial roadmap for investors, or potentially 'Regulatory Filings' (RNS) as a general corporate announcement. Given the focus on strategic financial guidance for investors, 'Investor Presentation' (IP) is the most accurate classification for this type of strategic disclosure. FY 2030
2025-09-02 Danish
Director's Dealing 2025
Director's Dealing Classification · 1% confidence The document title explicitly states 'Trading in Coloplast shares by board members, executives or associated persons'. This directly corresponds to the definition of Director's Dealing (insider trades). Although the text is very short and points to an attachment ('Please see enclosed pdf.'), the specific subject matter (director trading) overrides the general 'RPA' rule, as 'DIRS' is a more precise classification than 'RNS' or 'RPA'. The content is clearly about insider transactions.
2025-05-08 English
Director's Dealing 2025
Director's Dealing Classification · 1% confidence The document is titled "Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med Coloplast aktier og tilknyttede værdipapirer" (Notification of transactions in Coloplast shares and related securities by senior employees and their closely associated persons). It explicitly references compliance with the Market Abuse Regulation (Markedsmisbrugsforordningen art. 19) and details the purchase of shares by an individual closely associated with a director (Niels Peter Louis-Hansen, Vice Chairman). This content directly corresponds to the reporting requirements for insider transactions by directors and executives. This matches the definition for Director's Dealing (DIRS).
2025-05-08 English
Director's Dealing 2025
Director's Dealing Classification · 1% confidence The document explicitly states its purpose in the title: "Report on transactions of executives and related parties in Coloplast shares and related securities." It references compliance with the Market Abuse Regulation article 19, which mandates reporting of insider transactions. The content details the purchase of shares by a related party to a director, including transaction dates, prices, and volumes. This perfectly matches the definition of Director's Dealing (DIRS).
2025-05-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.